These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 27746352)

  • 1. Nanoparticles-protein interaction: Role in protein aggregation and clinical implications.
    Parveen R; Shamsi TN; Fatima S
    Int J Biol Macromol; 2017 Jan; 94(Pt A):386-395. PubMed ID: 27746352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mechanistic insight into protein-ligand interaction, folding, misfolding, aggregation and inhibition of protein aggregates: An overview.
    Chandel TI; Zaman M; Khan MV; Ali M; Rabbani G; Ishtikhar M; Khan RH
    Int J Biol Macromol; 2018 Jan; 106():1115-1129. PubMed ID: 28890370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo aspects of protein folding and quality control.
    Balchin D; Hayer-Hartl M; Hartl FU
    Science; 2016 Jul; 353(6294):aac4354. PubMed ID: 27365453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osmolytes: A Possible Therapeutic Molecule for Ameliorating the Neurodegeneration Caused by Protein Misfolding and Aggregation.
    Kushwah N; Jain V; Yadav D
    Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31941036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of HSP70 and its co-chaperones in protein misfolding, aggregation and disease.
    Duncan EJ; Cheetham ME; Chapple JP; van der Spuy J
    Subcell Biochem; 2015; 78():243-73. PubMed ID: 25487025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms and Functions of Spatial Protein Quality Control.
    Sontag EM; Samant RS; Frydman J
    Annu Rev Biochem; 2017 Jun; 86():97-122. PubMed ID: 28489421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Layers of structure and function in protein aggregation.
    Tanaka M; Komi Y
    Nat Chem Biol; 2015 Jun; 11(6):373-7. PubMed ID: 25978986
    [No Abstract]   [Full Text] [Related]  

  • 8. Nanoparticle-induced cell culture models for degenerative protein aggregation diseases.
    Chen M; von Mikecz A
    Inhal Toxicol; 2009 Jul; 21 Suppl 1():110-4. PubMed ID: 19558242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-amyloid compounds protect from silica nanoparticle-induced neurotoxicity in the nematode C. elegans.
    Scharf A; Gührs KH; von Mikecz A
    Nanotoxicology; 2016; 10(4):426-35. PubMed ID: 26444998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases.
    Soto C; Pritzkow S
    Nat Neurosci; 2018 Oct; 21(10):1332-1340. PubMed ID: 30250260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The curious cases of nanoparticle induced amyloidosis during protein corona formation and anti-amyloidogenic nanomaterials: Paradox or prejudice?
    Randhawa S; Abidi SMS; Dar AI; Acharya A
    Int J Biol Macromol; 2021 Dec; 193(Pt A):1009-1020. PubMed ID: 34728302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Methods for Structural Analysis of Protein Aggregation.
    Khan E; Mishra SK; Kumar A
    Protein Pept Lett; 2017; 24(4):331-339. PubMed ID: 28176657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-Nanoparticle Interaction-Induced Changes in Protein Structure and Aggregation.
    Kim Y; Ko SM; Nam JM
    Chem Asian J; 2016 Jul; 11(13):1869-77. PubMed ID: 27062521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective protein folding and aggregation as the basis of neurodegenerative diseases: the darker aspect of proteins.
    Naeem A; Fazili NA
    Cell Biochem Biophys; 2011 Nov; 61(2):237-50. PubMed ID: 21573992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid formation characteristics of GNNQQNY from yeast prion protein Sup35 and its seeding with heterogeneous polypeptides.
    Haratake M; Takiguchi T; Masuda N; Yoshida S; Fuchigami T; Nakayama M
    Colloids Surf B Biointerfaces; 2017 Jan; 149():72-79. PubMed ID: 27736724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misfolding and aggregation in neurodegenerative diseases: protein quality control machinery as potential therapeutic clearance pathways.
    Koszła O; Sołek P
    Cell Commun Signal; 2024 Aug; 22(1):421. PubMed ID: 39215343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A health concern regarding the protein corona, aggregation and disaggregation.
    Falahati M; Attar F; Sharifi M; Haertlé T; Berret JF; Khan RH; Saboury AA
    Biochim Biophys Acta Gen Subj; 2019 May; 1863(5):971-991. PubMed ID: 30802594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein folding, misfolding and quality control: the role of molecular chaperones.
    Papsdorf K; Richter K
    Essays Biochem; 2014; 56():53-68. PubMed ID: 25131586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contribution of biophysical and structural studies of protein self-assembly to the design of therapeutic strategies for amyloid diseases.
    Cremades N; Dobson CM
    Neurobiol Dis; 2018 Jan; 109(Pt B):178-190. PubMed ID: 28709995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural studies on the mechanism of protein aggregation in age related neurodegenerative diseases.
    Eftekharzadeh B; Hyman BT; Wegmann S
    Mech Ageing Dev; 2016 Jun; 156():1-13. PubMed ID: 27005270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.